RB1 and colorectal carcinoma: The results of this study revealed that HR488B decreased the expression of E2F1 by attenuating the dissociation of the E2F1/Rb/HDAC1 complex mediated by decreasing the phosphorylation of Rb protein, thereby inhibiting CRC development.